SIGHT SCIENCES, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
SIGHT SCIENCES, INC. (SGHT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$38.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-04
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$38.90M.
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$51.30M, a 192.10% decline from fiscal 2023.
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $55.70M, a 35.23% decline from fiscal 2022.
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $86.00M, a 36.51% increase from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$38.90M 10-K · filed 2026-03-04 | |
| 2024-12-31 | -$51.30M 10-K · filed 2026-03-04 | $51.30M 10-K · filed 2025-03-07 |
| 2023-12-31 | $55.70M 10-K · filed 2025-03-07 | |
| 2022-12-31 | $86.00M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $63.00M 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |